About Cellartis
Cellartis is a Healthcare company based in Goteborg (Sweden) founded in 2004, and was acquired by Cellectis in September 2011. Stem Cell Research Products from Takara Clontech. Cellartis has raised $9.45 million across 2 funding rounds from investors including Cellectis, Bio Fund Management and InnovationsKapital. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified.
Company details
Cellartis was founded in 2004 in Gothenburg, Sweden, as a biotechnology firm focused on human embryonic stem cell technologies. Research, development, and manufacturing of stem cell lines and derived functional cells are conducted for the research community and industry. More than 30 stem cell lines are offered, aiding pharmaceutical discovery, regenerative medicine, and toxicology applications. The company was acquired by Cellectis SA in 2011 and by Takara Bio in 2014.
- Headquarters Goteborg, Sweden
- Stage Acquired
- SectorsHealthcare
- Website CellArtis.com
- Social LinkedIn
- Acquired by Cellectis (Sep 2011)
Funding Insights of Cellartis
Cellartis has successfully raised a total of $9.45M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $2.3 million completed in January 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9.45M
- Total Rounds 2
- Last Round Grant — $2.3M
- First Round $9.45M
(Dec 2005)
- Investors Count 3
All 2 funding rounds of Cellartis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2007 | $2.3M | Grant | – | – | – |
| Dec 2005 | $9.45M | Series A | – | Bio Fund Management |
4 investors in total: 4 institutional.
Investors in Cellartis
Cellartis has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Cellectis, Bio Fund Management and InnovationsKapital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage life sciences startups are funded by Bio Fund Management. | biofund.fi | Helsinki, Finland | ||
| innkap.se | ||||
Offers software for converting and creating electronic forms efficiently. | 1985 | texcel.com | Maynard, United States | |
Cancer immunotherapies are developed via gene-edited CAR T-cells. | 1999 | cellectis.com | Paris, France |
Investor details for Cellartis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Cellartis
4 dated milestones of Cellartis across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Cellartis is founded.
- Funding First funding round of $9.4M.
- Funding Latest funding round, Grant, of $2.3M.
- Exit Acquired by Cellectis.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cellartis
Complete news archive for Cellartis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cellartis
Cellartis was founded in 2004 and raised its 1st funding round 1 year after it was founded.
Cellartis is headquartered in Goteborg, Sweden. It is registered at Goteborg, Vastra Gotaland, Sweden.
Cellartis is a funded company, having raised a total of $9.45M across 2 funding rounds to date. The company's 1st funding round was a Series A of $9.45M, raised on Dec 2005.
Cellartis was founded in 2004 in Gothenburg, Sweden, as a biotechnology firm focused on human embryonic stem cell technologies. Research, development, and manufacturing of stem cell lines and derived functional cells are conducted for the research community and industry. More than 30 stem cell lines are offered, aiding pharmaceutical discovery, regenerative medicine, and toxicology applications. The company was acquired by Cellectis SA in 2011 and by Takara Bio in 2014.
Cellartis has 4 investors. Key investors include Cellectis, Bio Fund Management, InnovationsKapital, and Texcel.
Yes. Cellartis was acquired by Cellectis in September 2011.